Neuca S.A.
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more
Market Cap & Net Worth: Neuca S.A. (NEU)
Neuca S.A. (WAR:NEU) has a market capitalization of $784.83 Million (zł3.26 Billion) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #13265 globally and #38 in its home market, demonstrating a -2.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neuca S.A.'s stock price zł725.00 by its total outstanding shares 4501244 (4.50 Million).
Neuca S.A. Market Cap History: 2015 to 2026
Neuca S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $332.06 Million to $792.41 Million (9.11% CAGR).
Index Memberships
Neuca S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$22.01 Billion | 1.26% | #17 of 40 |
Weight: Neuca S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neuca S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neuca S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Neuca S.A.'s market cap is 0.07 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
6.13x
Neuca S.A.'s market cap is 6.13 times its annual earnings
9.22x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $332.06 Million | $6.95 Billion | $101.28 Million | 0.05x | 3.28x |
| 2016 | $365.34 Million | $7.08 Billion | $111.73 Million | 0.05x | 3.27x |
| 2017 | $255.24 Million | $7.49 Billion | $94.50 Million | 0.03x | 2.70x |
| 2018 | $237.74 Million | $7.75 Billion | $98.27 Million | 0.03x | 2.42x |
| 2019 | $378.11 Million | $8.28 Billion | $117.66 Million | 0.05x | 3.21x |
| 2020 | $661.79 Million | $9.25 Billion | $141.79 Million | 0.07x | 4.67x |
| 2021 | $866.47 Million | $9.86 Billion | $150.66 Million | 0.09x | 5.75x |
| 2022 | $681.36 Million | $11.23 Billion | $137.24 Million | 0.06x | 4.96x |
| 2023 | $985.71 Million | $11.81 Billion | $146.27 Million | 0.08x | 6.74x |
| 2024 | $945.05 Million | $12.61 Billion | $154.24 Million | 0.07x | 6.13x |
Competitor Companies of NEU by Market Capitalization
Companies near Neuca S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Neuca S.A. by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Neuca S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Neuca S.A.'s market cap moved from $332.06 Million to $ 792.41 Million, with a yearly change of 9.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł792.41 Million | -10.07% |
| 2025 | zł881.18 Million | -6.76% |
| 2024 | zł945.05 Million | -4.13% |
| 2023 | zł985.71 Million | +44.67% |
| 2022 | zł681.36 Million | -21.36% |
| 2021 | zł866.47 Million | +30.93% |
| 2020 | zł661.79 Million | +75.03% |
| 2019 | zł378.11 Million | +59.04% |
| 2018 | zł237.74 Million | -6.85% |
| 2017 | zł255.24 Million | -30.14% |
| 2016 | zł365.34 Million | +10.02% |
| 2015 | zł332.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Neuca S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $784.83 Million USD |
| MoneyControl | $784.83 Million USD |
| MarketWatch | $784.83 Million USD |
| marketcap.company | $784.83 Million USD |
| Reuters | $784.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.